PRESS RELEASE published on 09/11/2024 at 15:07, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. files Form 8.3 for Hargreaves Lansdown plc disclosing 3.93% ownership, with 18,636,155 relevant securities held Form 8.3 Relevant Securities Vanguard Group Ownership Disclosure Hargreaves Lansdown Plc
PRESS RELEASE published on 09/11/2024 at 15:06, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses 4.90% interest in Smith (DS) plc. Public opening position disclosure as per Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Disclosure Rule 8.3 Smith (DS) Plc Interests
PRESS RELEASE published on 09/11/2024 at 15:05, 1 year 11 months ago Form 8.3 - The Vanguard Group, Inc.: REA Group Ltd The Vanguard Group, Inc. discloses a 2.08% ownership in REA Group Ltd as of 10th Sept 2024, partaking in dealings with Rightmove plc The Vanguard Group Ownership Disclosure Dealings Rightmove Plc REA Group Ltd
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Director/PDMR Shareholding easyJet plc notified on 11 Sep 2024 of director share purchases under Share Incentive Plan. PDMRs bought 31 shares each at £4.87 PDMR Share Incentive Plan Shareholding EasyJet Plc Director
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago FTSE Russell US Wealth Survey Results FTSE Russell US Wealth survey reveals US investors cautious due to economy & election, empowered by index funds & advisors. Majority believe election impacts finances but only 21% adjusting portfolios Financial Advisors US Investors FTSE Russell Index Funds Election Impact
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference Xenetic Biosciences presented at H.C. Wainwright 26th Annual Global Investment Conference. The biopharmaceutical company focuses on immune-oncology technologies for hard-to-treat cancers Xenetic Biosciences Biopharmaceutical Immune-oncology JTC Team Cancers
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Visual Edge IT Brings Technology Solutions to the Printing Industry Meet a Pro Football Hall of Famer at Visual Edge IT booth to raise awareness for cybersecurity in the printing industry. Get a security assessment to prevent financial risks Cybersecurity Printing Industry Security Assessment Visual Edge IT Pro Football Hall Of Famer
PRESS RELEASE published on 09/11/2024 at 15:00, 1 year 11 months ago Applied DNA Launches Mpox Clade I and Clade II Testing Service Applied DNA Sciences expands clinical testing to include detection of Mpox Clade I and Clade II. ADCL, a NYSDOH CLEP-permitted laboratory, offers Linea Mpox Virus 1.0 Assay from Stony Brook, NY Applied DNA Sciences Linea Mpox Virus 1.0 Assay Mpox Testing ADCL Clinical Laboratory
PRESS RELEASE published on 09/11/2024 at 14:39, 1 year 11 months ago Edison issues report on Partners Group Private Equity (PEY/PEYS) Edison issues report on Partners Group Private Equity, highlighting successful realisation proceeds and strong performance indicators. Click for full report Edison Investment Performance Realisation Proceeds Partners Group Private Equity Exit Candidates
PRESS RELEASE published on 09/11/2024 at 14:30, 1 year 11 months ago Alta Copper Announces Non-Brokered Financing With Fortescue Ltd. Alta Copper Corp. announces Cdn.$2.5 million non-brokered Private Placement with Fortescue Ltd. for its Cañariaco copper project. Common Shares sold at Cdn$0.54 each Private Placement Common Shares Alta Copper Corp. Cañariaco Copper Project Fortescue Ltd.
Published on 09/11/2026 at 04:00, 5 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 30 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 45 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 50 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 20 minutes ago Availability of the 2026 Interim Financial Report
